Eva Biewald

1.4k total citations
45 papers, 385 citations indexed

About

Eva Biewald is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Eva Biewald has authored 45 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Eva Biewald's work include Ocular Oncology and Treatments (42 papers), Cancer-related Molecular Pathways (9 papers) and Corneal Surgery and Treatments (6 papers). Eva Biewald is often cited by papers focused on Ocular Oncology and Treatments (42 papers), Cancer-related Molecular Pathways (9 papers) and Corneal Surgery and Treatments (6 papers). Eva Biewald collaborates with scholars based in Germany, Switzerland and Netherlands. Eva Biewald's co-authors include Norbert Bornfeld, Dietmar Lohmann, Petra Temming, W. Sauerwein, Anja Viehmann, Nikolaos E. Bechrakis, Dirk Flühs, Michael M. Schündeln, Marina Arendt and K. Metz and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Ophthalmology.

In The Last Decade

Eva Biewald

38 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Biewald Germany 12 311 110 80 78 69 45 385
Junyang Zhao China 7 327 1.1× 149 1.4× 84 1.1× 128 1.6× 77 1.1× 15 465
Kiran Turaka United States 10 328 1.1× 104 0.9× 60 0.8× 101 1.3× 44 0.6× 20 405
Renelle Pointdujour‐Lim United States 12 236 0.8× 120 1.1× 40 0.5× 87 1.1× 48 0.7× 37 342
Christina Stathopoulos Switzerland 9 377 1.2× 106 1.0× 131 1.6× 107 1.4× 85 1.2× 29 529
Jaume Català Spain 14 441 1.4× 117 1.1× 153 1.9× 116 1.5× 55 0.8× 24 497
Erika Damato United Kingdom 13 356 1.1× 71 0.6× 55 0.7× 100 1.3× 63 0.9× 23 431
David Ancona‐Lezama United States 11 463 1.5× 155 1.4× 102 1.3× 108 1.4× 95 1.4× 39 548
CarolL Shields United States 7 240 0.8× 90 0.8× 63 0.8× 69 0.9× 47 0.7× 16 338
Ashwin Mallipatna Canada 12 356 1.1× 106 1.0× 180 2.3× 84 1.1× 66 1.0× 32 465
Susan Houghton Switzerland 6 286 0.9× 77 0.7× 101 1.3× 44 0.6× 61 0.9× 7 317

Countries citing papers authored by Eva Biewald

Since Specialization
Citations

This map shows the geographic impact of Eva Biewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Biewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Biewald more than expected).

Fields of papers citing papers by Eva Biewald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Biewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Biewald. The network helps show where Eva Biewald may publish in the future.

Co-authorship network of co-authors of Eva Biewald

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Biewald. A scholar is included among the top collaborators of Eva Biewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Biewald. Eva Biewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Bernard, Eva Biewald, Nika Guberina, et al.. (2025). Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas. Radiation Oncology. 20(1). 22–22.
2.
Schramm, Kathrin, Stefan Schönberger, Ines B. Brecht, et al.. (2025). Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition. Pediatric Blood & Cancer. 73(2). e32147–e32147.
3.
Budeus, Bettina, Saskia Ting, Deniz Kanber, et al.. (2024). In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell Death and Disease. 15(12). 905–905.
4.
Afanasyeva, Elena, M. Schneider, Christopher Schröder, et al.. (2024). A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications Biology. 7(1). 919–919. 2 indexed citations
5.
Biewald, Eva, Maja Guberina, Henning Thomasen, et al.. (2024). Surgical Outcome After Treatment of Radiation-Induced Scleral Necrosis in Patients With Uveal Melanoma. Cornea. 43(11). 1375–1382. 2 indexed citations
6.
Göricke, Sophia, M. J. Lever, Saskia Ting, et al.. (2023). Preoperative Detection of Local Tumor Extent in Patients with Advanced Retinoblastoma: Predictive Value of MRI and Clinical Findings. Klinische Monatsblätter für Augenheilkunde. 242(11). 1122–1131.
7.
Busch, Maike, et al.. (2023). Trefoil Family Factor Peptide 1—A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy. Cancers. 15(19). 4828–4828. 7 indexed citations
8.
Ketteler, Petra, et al.. (2023). PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma. Frontiers in Oncology. 13. 1144951–1144951. 3 indexed citations
9.
Beier, Manfred, et al.. (2022). ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis. International Journal of Molecular Sciences. 23(20). 12621–12621. 3 indexed citations
10.
Busch, Maike, Eva Biewald, Nikolaos E. Bechrakis, et al.. (2022). TFF1 in Aqueous Humor—A Potential New Biomarker for Retinoblastoma. Cancers. 14(3). 677–677. 14 indexed citations
11.
Bornfeld, Norbert, Henrike Westekemper, Martin Stuschke, et al.. (2022). Long-Term Results after Intraocular Surgery in Treated Retinoblastoma Eyes. Ocular Oncology and Pathology. 8(3). 161–167. 2 indexed citations
12.
Biewald, Eva, Dirk Geismar, Henrike Westekemper, et al.. (2021). Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers. 13(8). 1862–1862. 7 indexed citations
13.
Bornfeld, Norbert, Dirk Flühs, Martin Stuschke, et al.. (2021). Combination of Brachytherapy and Intravitreal Chemotherapy in the Treatment of Retinoblastoma with Vitreous Seeding. Ocular Oncology and Pathology. 8(1). 64–70. 11 indexed citations
14.
Biewald, Eva, Nikolaos E. Bechrakis, Dirk Geismar, et al.. (2020). Long-Term Clinical Results and Management following Vitrectomy in Undetected Retinoblastoma Eyes. Ocular Oncology and Pathology. 6(4). 244–250. 3 indexed citations
15.
Stenzel, Elena, Sophia Göricke, Petra Temming, et al.. (2019). Feasibility of intra-arterial chemotherapy for retinoblastoma: experiences in a large single center cohort study. Neuroradiology. 61(3). 351–357. 16 indexed citations
16.
Biewald, Eva, Norbert Bornfeld, K. Metz, et al.. (2019). Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. British Journal of Ophthalmology. 104(8). 1171–1175. 12 indexed citations
17.
Biewald, Eva, et al.. (2014). Neue Therapiestrategien beim Retinoblastom. Der Ophthalmologe. 111(4). 379–382. 3 indexed citations
18.
Biewald, Eva, K. Metz, & Norbert Bornfeld. (2013). Stellenwert der transretinalen Tumorbiopsie als diagnostisches und prädiktives Instrument. Der Ophthalmologe. 110(9). 882–884. 2 indexed citations
19.
Temming, Petra, Anja Viehmann, Eva Biewald, & Dietmar Lohmann. (2013). Sporadic unilateral retinoblastoma or first sign of bilateral disease?. British Journal of Ophthalmology. 97(4). 475–480. 16 indexed citations
20.
Biewald, Eva, et al.. (2012). Longterm Results After Endoresection Of Large Uveal Melanomas With Preoperative Stereotactic Radiation And Adjuvant Brachytherapy. Investigative Ophthalmology & Visual Science. 53(14). 3413–3413. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junyang Zhao Breakdown of academic impact, for papers by Kiran Turaka Breakdown of academic impact, for papers by Renelle Pointdujour‐Lim Breakdown of academic impact, for papers by Christina Stathopoulos Breakdown of academic impact, for papers by Jaume Català Breakdown of academic impact, for papers by Erika Damato Breakdown of academic impact, for papers by David Ancona‐Lezama Breakdown of academic impact, for papers by CarolL Shields Breakdown of academic impact, for papers by Ashwin Mallipatna Breakdown of academic impact, for papers by Susan Houghton
Rankless by CCL
2026